• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米海绵:一种被忽视的有前途的对抗 SARS-CoV-2 的策略。

Nanosponges: An overlooked promising strategy to combat SARS-CoV-2.

机构信息

Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.

Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

Drug Discov Today. 2022 Oct;27(10):103330. doi: 10.1016/j.drudis.2022.07.015. Epub 2022 Jul 28.

DOI:10.1016/j.drudis.2022.07.015
PMID:35908684
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9330373/
Abstract

Among explored nanomaterials, nanosponge-based systems have exhibited inhibitory effects for the biological neutralization of, and antiviral delivery against, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). More studies could pave the path for clarification of their biological neutralization mechanisms as well as the assessment of their long-term biocompatibility and biosafety issues before clinical translational studies. In this review, we discuss recent advances pertaining to antiviral delivery and inhibitory effects of nanosponges against SARS-CoV-2, focusing on important challenges and opportunities. Finally, as promising approaches for recapitulating the complex structure of different organs/tissues of the body, we discuss the use of 3D in vitro models to investigate the mechanism of SARS-CoV-2 infection and to find therapeutic targets to better manage and eradicate coronavirus 2019 (COVID-19).

摘要

在已探索的纳米材料中,基于纳米海绵的系统已显示出对严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的生物学中和及抗病毒传递的抑制作用。更多的研究可以为阐明其生物学中和机制以及评估其长期生物相容性和生物安全问题铺平道路,然后再进行临床转化研究。在这篇综述中,我们讨论了与纳米海绵对 SARS-CoV-2 的抗病毒传递和抑制作用相关的最新进展,重点讨论了重要的挑战和机遇。最后,作为模拟人体不同器官/组织复杂结构的有前途的方法,我们讨论了使用 3D 体外模型来研究 SARS-CoV-2 感染的机制,并寻找治疗靶点,以更好地管理和消除 2019 年冠状病毒(COVID-19)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/9330373/c40857e363ab/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/9330373/58e0fb03f586/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/9330373/8fccd5fe7f9c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/9330373/05a3e6b084fc/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/9330373/04fad11b8adb/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/9330373/ac1f51cbc1ed/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/9330373/e3ab33e30f8d/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/9330373/2856a7b7f51c/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/9330373/c40857e363ab/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/9330373/58e0fb03f586/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/9330373/8fccd5fe7f9c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/9330373/05a3e6b084fc/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/9330373/04fad11b8adb/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/9330373/ac1f51cbc1ed/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/9330373/e3ab33e30f8d/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/9330373/2856a7b7f51c/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b45/9330373/c40857e363ab/gr7_lrg.jpg

相似文献

1
Nanosponges: An overlooked promising strategy to combat SARS-CoV-2.纳米海绵:一种被忽视的有前途的对抗 SARS-CoV-2 的策略。
Drug Discov Today. 2022 Oct;27(10):103330. doi: 10.1016/j.drudis.2022.07.015. Epub 2022 Jul 28.
2
Surface Glycan Modification of Cellular Nanosponges to Promote SARS-CoV-2 Inhibition.细胞纳米海绵表面糖基化修饰促进 SARS-CoV-2 抑制。
J Am Chem Soc. 2021 Oct 27;143(42):17615-17621. doi: 10.1021/jacs.1c07798. Epub 2021 Oct 14.
3
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.SARS-CoV-2 及其他人类致病冠状病毒的抗病毒药物和可用药靶的现状。
Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26.
4
Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets.抗 SARS-CoV-2 感染的 FDA 批准药物在雪貂中的抗病毒疗效。
mBio. 2020 May 22;11(3):e01114-20. doi: 10.1128/mBio.01114-20.
5
Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era.抗菌肽:应对 SARS-CoV2 时代多药耐药的有前途工具。
Microbiol Res. 2022 Dec;265:127206. doi: 10.1016/j.micres.2022.127206. Epub 2022 Sep 21.
6
Recent advances in potential drug therapies combating COVID-19 and related coronaviruses-A perspective.近期对抗 COVID-19 及相关冠状病毒的潜在药物疗法的进展——一种观点。
Food Chem Toxicol. 2021 Aug;154:112333. doi: 10.1016/j.fct.2021.112333. Epub 2021 Jun 10.
7
Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review.天然类黄酮对抗 SARS-CoV-2 靶点的有前景的抗病毒活性:系统评价。
Int J Mol Sci. 2021 Oct 14;22(20):11069. doi: 10.3390/ijms222011069.
8
[Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].[氯丙嗪在新冠病毒肺炎治疗中的重新应用:恢复研究]
Encephale. 2020 Jun;46(3S):S35-S39. doi: 10.1016/j.encep.2020.04.010. Epub 2020 Apr 29.
9
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.瑞德西韦、洛匹那韦/利托那韦和氯喹/羟氯喹影响新型 SARS-CoV-2 的抗病毒机制研究进展。
Biomed Pharmacother. 2020 Nov;131:110668. doi: 10.1016/j.biopha.2020.110668. Epub 2020 Aug 24.
10
The Antiviral, Anti-Inflammatory Effects of Natural Medicinal Herbs and Mushrooms and SARS-CoV-2 Infection.天然草药和蘑菇的抗病毒、抗炎作用与 SARS-CoV-2 感染。
Nutrients. 2020 Aug 25;12(9):2573. doi: 10.3390/nu12092573.

引用本文的文献

1
State-of-art high-performance Nano-systems for mutated coronavirus infection management: From Lab to Clinic.用于突变型冠状病毒感染管理的前沿高性能纳米系统:从实验室到临床。
OpenNano. 2022 Nov-Dec;8:100078. doi: 10.1016/j.onano.2022.100078. Epub 2022 Sep 10.
2
In vitro and preclinical evaluation of the antifungal activity of 6-methoxy-1 H-indole-2-carboxylic acid produced by Bacillus toyonensis strain OQ071612 formulated as nanosponge hydrogel.对由toyonensis芽孢杆菌菌株OQ071612产生的6-甲氧基-1H-吲哚-2-羧酸制成纳米海绵水凝胶后的抗真菌活性进行体外和临床前评估。
Microb Cell Fact. 2025 Apr 1;24(1):77. doi: 10.1186/s12934-025-02688-y.
3

本文引用的文献

1
SARS-CoV-2 getting into the brain; neurological phenotype of COVID-19, and management by nano-biotechnology.严重急性呼吸综合征冠状病毒2进入大脑;冠状病毒病的神经表型以及纳米生物技术的管理
Neural Regen Res. 2023 Mar;18(3):519-520. doi: 10.4103/1673-5374.346486.
2
Versatile Applications of Nanosponges in Biomedical Field: A Glimpse on SARS-CoV-2 Management.纳米海绵在生物医学领域的多功能应用:对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)管理的一瞥
Bionanoscience. 2022;12(3):1018-1031. doi: 10.1007/s12668-022-01000-1. Epub 2022 Jun 20.
3
Nanotechnology-Assisted Metered-Dose Inhalers (MDIs) for High-Performance Pulmonary Drug Delivery Applications.
Nanosponge hydrogel of octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl) propanoate of Alcaligenes faecalis.
粪产碱杆菌十八烷基 3-(3,5-二叔丁基-4-羟基苯基)丙酸盐纳米海绵水凝胶。
Appl Microbiol Biotechnol. 2024 Dec;108(1):100. doi: 10.1007/s00253-023-12819-3. Epub 2024 Jan 12.
4
Nanosponge: A promising and intriguing strategy in medical and pharmaceutical Science.纳米海绵:医学和制药科学中一种有前景且引人入胜的策略。
Heliyon. 2023 Dec 6;10(1):e23303. doi: 10.1016/j.heliyon.2023.e23303. eCollection 2024 Jan 15.
纳米技术辅助计量吸入器(MDIs)在高性能肺部药物输送中的应用。
Pharm Res. 2022 Nov;39(11):2831-2855. doi: 10.1007/s11095-022-03286-y. Epub 2022 May 12.
4
Quantum dots against SARS-CoV-2: diagnostic and therapeutic potentials.用于对抗2019冠状病毒病的量子点:诊断和治疗潜力
J Chem Technol Biotechnol. 2022 Jul;97(7):1640-1654. doi: 10.1002/jctb.7036. Epub 2022 Feb 4.
5
Cyclodextrin-Based Nanosponges: Overview and Opportunities.基于环糊精的纳米海绵:概述与机遇
Front Chem. 2022 Mar 24;10:859406. doi: 10.3389/fchem.2022.859406. eCollection 2022.
6
SARS-CoV-2 Omicron variant: A next phase of the COVID-19 pandemic and a call to arms for system sciences and precision medicine.严重急性呼吸综合征冠状病毒2型奥密克戎变种:新冠疫情的新阶段以及对系统科学和精准医学的战斗号召。
MedComm (2020). 2022 Feb 11;3(1):e119. doi: 10.1002/mco2.119. eCollection 2022 Mar.
7
A highly immunogenic live-attenuated vaccine candidate prevents SARS-CoV-2 infection and transmission in hamsters.一种具有高度免疫原性的减毒活疫苗候选物可预防仓鼠感染和传播严重急性呼吸综合征冠状病毒2(SARS-CoV-2)。
Innovation (Camb). 2022 Mar 29;3(2):100221. doi: 10.1016/j.xinn.2022.100221. Epub 2022 Mar 2.
8
The ascension of nanosponges as a drug delivery carrier: preparation, characterization, and applications.纳米海绵作为药物传递载体的兴起:制备、表征和应用。
J Mater Sci Mater Med. 2022 Mar 4;33(3):28. doi: 10.1007/s10856-022-06652-9.
9
Stabilization and Anticancer Enhancing Activity of the Peptide Nisin by Cyclodextrin-Based Nanosponges against Colon and Breast Cancer Cells.基于环糊精的纳米海绵对乳链菌肽的稳定化及抗癌增强活性研究:针对结肠癌细胞和乳腺癌细胞
Polymers (Basel). 2022 Feb 1;14(3):594. doi: 10.3390/polym14030594.
10
Synthesis and Characterization of Carboxymethyl Chitosan Nanosponges with Cyclodextrin Blends for Drug Solubility Improvement.用于改善药物溶解度的环糊精共混羧甲基壳聚糖纳米海绵的合成与表征
Gels. 2022 Jan 12;8(1):55. doi: 10.3390/gels8010055.